Radiotherapy for locally recurrent prostate cancer

Area of Science:

• Oncology
• Urology
• Radiation Oncology

Background:

• Optimal treatment for prostate cancer recurrence post-radical prostatectomy remains controversial.
• Managing rising prostate-specific antigen (PSA) without overt metastases after prostatectomy presents clinical challenges.
• Distinguishing local recurrence from distant metastases is critical for treatment selection.

Purpose of the Study:

• To discuss factors influencing treatment recommendations for patients with recurrent prostate cancer.
• To present evaluation and management strategies for biochemical recurrence after prostatectomy.
• To address the controversy surrounding adjuvant radiotherapy versus observation.

Main Methods:

• Review of a randomized controlled trial comparing adjuvant radiotherapy to observation.
• Analysis of factors influencing the distinction between local recurrence and distant metastases.
• Discussion of clinical decision-making in managing rising PSA levels.

Main Results:

• Adjuvant radiotherapy demonstrated significantly higher freedom from recurrence compared to observation.
• The study provides evidence to inform the debate on early versus delayed treatment based on PSA rise.

Conclusions:

• Adjuvant radiotherapy may be a beneficial option for select patients at high risk for recurrence.
• Accurate assessment of PSA kinetics is crucial for guiding treatment decisions in recurrent prostate cancer.
• A tailored approach considering individual patient factors is essential for effective management.